rss
Evid Based Nurs 12:14 doi:10.1136/ebn.12.1.14
  • Treatment

Benefits of early intensive glucose control in preventing diabetes-related complications were sustained for up to 10 years

R R Holman

Dr R R Holman, Churchill Hospital, Oxford, UK; rury.holman@dtu.ox.ac.uk

QUESTION

In patients with type 2 diabetes, do the benefits of early intensive glucose control in preventing diabetes-related complications continue after the intervention is stopped?

METHODS

Design:

randomised controlled trial (UK Prospective Diabetes Study [UKPDS]).

Allocation:

{concealed}.*

Blinding:

blinded (outcome adjudication committee).

Follow-up period:

median 9 years after the end of the trial, 17 years total.

Setting:

23 centres in the UK.

Patients:

4209 patients 25–65 years of age {mean age 53 y, 60% men}* who had newly diagnosed type 2 diabetes and fasting plasma glucose concentrations >6.0 mmol/l (108 mg/dl) and <15.0 mmol/l (270 mg/dl) after 3 months of dietary therapy. Exclusion criteria included ketonuria, elevated serum creatinine, recent myocardial infarction, angina, …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article